Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen
about
Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistanceChloroquine is grossly under dosed in young children with malaria: implications for drug resistanceSlow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon.Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations.Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy.Pharmacokinetics, pharmacodynamics, and allometric scaling of chloroquine in a murine malaria model.Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study.Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border.Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria.Population pharmacokinetics of azithromycin and chloroquine in healthy adults and paediatric malaria subjects following oral administration of fixed-dose azithromycin and chloroquine combination tablets.Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children.Population pharmacokinetics of sulfadoxine and pyrimethamine in Malawian children with malaria.Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquineEditors' pick 2009.Is chloroquine making a comeback?Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations.Population Pharmacokinetic properties of Sulfadoxine and Pyrimethamine: A pooled analysis to Inform Optimal Dosing in African Children with Uncomplicated Malaria.The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
P2860
Q28472222-5F5B34E2-54E1-4F60-AE65-0965CCA1777FQ28539103-058AC146-1D22-4CF2-A33A-853B48F459E6Q34142715-0D7EF776-2726-42D4-8A1B-87B1D9579530Q34299078-D2BC917F-5F99-4066-B3CC-3A8EA4CBF9D5Q34491448-8F5DDBCD-9CE9-4851-94F0-87E58ADC86DFQ34737758-B9E0F5B8-5D8B-44D3-9072-6861BE3E9869Q35139464-70ABAE05-0B5C-4BDF-8A7B-60372E002F48Q35941440-9695B245-22A0-4574-B557-E2E3200ED306Q36634918-2D340578-3E88-4F17-B3CC-B9D266CEA68FQ37108173-CB615B42-66BB-4C37-AC94-DA3E7B75EFFDQ37539850-FBFAA0F7-FCAF-4DA1-922E-3C17D79827ADQ38071558-234609BD-D1C4-41C1-82DD-AD1A9C7EFC78Q38901047-815F0ADA-4B62-4C5C-B8A5-2AFBEB465BB2Q39553303-3602A9A3-2C26-4D8A-95D1-E76976AE820FQ41819403-582962DA-1B33-4D00-B6FB-8DDC9025F69DQ42725873-8CB3821F-FBE6-4C7E-AB8F-AE0C24D226D5Q46405195-0E1C2861-CBBF-4C22-8288-9636F874ACF8Q49791979-7572987B-924B-4D60-A936-7C7D690E7E10Q56338338-9D74541F-A084-4121-9701-36E04054192E
P2860
Population pharmacokinetics of chloroquine and sulfadoxine and treatment response in children with malaria: suggestions for an improved dose regimen
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Population pharmacokinetics of ...... s for an improved dose regimen
@ast
Population pharmacokinetics of ...... s for an improved dose regimen
@en
type
label
Population pharmacokinetics of ...... s for an improved dose regimen
@ast
Population pharmacokinetics of ...... s for an improved dose regimen
@en
prefLabel
Population pharmacokinetics of ...... s for an improved dose regimen
@ast
Population pharmacokinetics of ...... s for an improved dose regimen
@en
P2093
P2860
P1476
Population pharmacokinetics of ...... s for an improved dose regimen
@en
P2093
Jasper W Ogwal-Okeng
Markus Jerling
Muhammed Ntale
Toufigh Gordi
Urban Hellgren
P2860
P304
P356
10.1111/J.1365-2125.2007.03050.X
P407
P577
2008-02-20T00:00:00Z